In pancreatic cancer, Macro_APOE activated CXCL1 and CXCL5 expression through LDL receptor and NF-κB signaling in tumor cells, thereby establishing immunosuppressive niches (19). This evidence concerns the gene NFKB1 and pancreatic neoplasm.